Literature DB >> 19876706

New oral anticoagulants: just a new therapeutic option or a real breakthrough?

Giancarlo Agnelli1, Cecilia Becattini.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19876706     DOI： 10.1007/s11739-009-0327-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  3 in total

1.  New direct thrombin inhibitors.

Authors:  Alessandro Squizzato; Francesco Dentali; Luigi Steidl; Walter Ageno
Journal:  Intern Emerg Med       Date:  2009-09-15       Impact factor: 3.397

2.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

Review 3.  Oral factor Xa inhibitors for thromboprophylaxis in major orthopedic surgery: a review.

Authors:  Davide Imberti; Chiara Dall'Asta; Matteo Giorgi Pierfranceschi
Journal:  Intern Emerg Med       Date:  2009-12       Impact factor: 3.397
  3 in total
  4 in total

1.  Fondaparinux in major orthopedic surgical patients.

Authors:  Roberto Santi; Laura Contino; Simona Gatto; Alessandro Levis
Journal:  Intern Emerg Med       Date:  2010-03-02       Impact factor: 3.397

Review 2.  Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?

Authors:  Andrea Rubboli; Jonas Oldgren; Francisco Marìn; Gregory Lip
Journal:  Intern Emerg Med       Date:  2013-10-18       Impact factor: 3.397

3.  New oral anticoagulants for thromboprophylaxis after elective total hip and knee arthroplasty.

Authors:  Richard J Friedman
Journal:  Thrombosis       Date:  2010-07-29

Review 4.  Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies.

Authors:  Emanuel Raschi; Matteo Bianchin; Walter Ageno; Roberto De Ponti; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.